Gujarat Themis Biosyn has informed that the meeting of the Board of Directors of the company is scheduled to be held on Wednesday 9th May, 2018, to appoint Chief Executive Officer (CEO) of the Company and to consider the Audited Financial Results for the Financial Year ended on 31st March, 2018. Further, the Trading Window in respect of the Company’s Securities shall remain closed for all Directors/Officer/Designated Employees of the Company from the opening of the trading hours on 30th April, 2018 till the closure of trading hours on 11th May, 2018.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: